| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
| 06/23/2009 | CA2433285C Blood lipid ameliorating composition |
| 06/23/2009 | CA2430967C Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/23/2009 | CA2415042C Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 06/23/2009 | CA2405046C Stabilized pharmaceutical compositions comprising a calcium blocker and an alkaline material |
| 06/23/2009 | CA2402991C Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 06/23/2009 | CA2398620C Pyrazine derivatives, pharmaceutical compositions containing them, and intermediates therefor |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
| 06/23/2009 | CA2373611C Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
| 06/23/2009 | CA2370023C Transdermal therapeutic system with a highly effective neuroleptic agent |
| 06/23/2009 | CA2367387C Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| 06/23/2009 | CA2362728C Improved aqueous solubility pharmaceutical formulations |
| 06/23/2009 | CA2355932C Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| 06/23/2009 | CA2350992C Preventive or therapeutic agents for myocarditis, dilated cardiomyopathy and heart failure comprising nf-kb inhibitors as active ingredients |
| 06/23/2009 | CA2347506C Quinazolinone derivatives |
| 06/23/2009 | CA2346643C Model and method for inhibiting angiogenesis using photodynamic therapy |
| 06/23/2009 | CA2336809C Water miscible macrolide solutions |
| 06/23/2009 | CA2326833C Indolyl-3-glyoxylic acid derivatives with antitumoral activity |
| 06/23/2009 | CA2320628C Chelated 8-hydroxyquinoline for the treatment of epithelial lesions |
| 06/23/2009 | CA2319686C Use of 2-amino-6-trifluoromehthoxybenzothiazole for preventing or treating cerebellum dysfunction |
| 06/23/2009 | CA2300148C Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
| 06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 06/23/2009 | CA2251696C Genetic suppression and replacement |
| 06/23/2009 | CA2214131C Trisubstituted phenyl derivatives |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/23/2009 | CA2163456C New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 06/23/2009 | CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 06/21/2009 | CA2646775A1 Cosmetic and pharmaceutical compositions |
| 06/19/2009 | CA2655335A1 Prolonged-release injectable suspensions of paliperidone palmitate, and dosage forms and delivery systems incorporating same |
| 06/18/2009 | WO2009076664A1 Method and composition for treating a serotonin receptor-mediated condition |
| 06/18/2009 | WO2009076663A1 Method and composition for treating an alpha adrenoceptor-mediated condition |
| 06/18/2009 | WO2009076631A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 06/18/2009 | WO2009076629A2 Compositions and methods for treating cancer |
| 06/18/2009 | WO2009076602A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076598A1 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer |
| 06/18/2009 | WO2009076593A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 06/18/2009 | WO2009076571A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076553A1 Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same |
| 06/18/2009 | WO2009076512A1 Carboxamidξ compounds and their use as chemokine receptor agonists |
| 06/18/2009 | WO2009076473A1 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl n,n-bis(2- chloroethyl)phosphorodiamidates |
| 06/18/2009 | WO2009076455A2 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 06/18/2009 | WO2009076449A1 Methods and compositions for treating poxviruses |
| 06/18/2009 | WO2009076440A2 Fungicidal bicyclic pyrazoles |
| 06/18/2009 | WO2009076408A2 3 -carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists |
| 06/18/2009 | WO2009076404A1 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 06/18/2009 | WO2009076399A2 Aminotetralin compounds as mu opioid receptor antagonists |
| 06/18/2009 | WO2009076397A2 Antiviral activity of cyclopentene nitro-ester and derivatives |
| 06/18/2009 | WO2009076387A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 06/18/2009 | WO2009076373A1 Heterocyclic kinase inhibitors |
| 06/18/2009 | WO2009076353A1 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
| 06/18/2009 | WO2009076352A1 Gamma secretase modulators |
| 06/18/2009 | WO2009076337A1 Gamma secretase modulators |
| 06/18/2009 | WO2009076321A2 Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| 06/18/2009 | WO2009076288A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
| 06/18/2009 | WO2009076243A2 Novel uses of chloramphenicol and analogues thereof |
| 06/18/2009 | WO2009076234A2 Synthesis methods of histone deacetylase inhibitors (hdacis) |
| 06/18/2009 | WO2009076212A1 Catalytic topoisomerase ii inhibitors |
| 06/18/2009 | WO2009076195A1 Treatment of drug-induced nausea with opioid antagonists |
| 06/18/2009 | WO2009076173A2 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | WO2009076170A2 Combinations of therapeutic agents for treating cancer |
| 06/18/2009 | WO2009076166A2 Oximyl hcv serine protease inhibitors |
| 06/18/2009 | WO2009076165A1 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption |
| 06/18/2009 | WO2009076141A2 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 06/18/2009 | WO2009075960A1 Ccr5 antagonists as therapeutic agents |
| 06/18/2009 | WO2009075954A1 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 06/18/2009 | WO2009075923A2 6, 11-bridged biaryl macrolides |
| 06/18/2009 | WO2009075874A1 Gamma secretase modulators |
| 06/18/2009 | WO2009075870A1 Compounds and methods for the treatment of cancer |
| 06/18/2009 | WO2009075857A2 Glycine transporter-1 inhibitors |
| 06/18/2009 | WO2009075841A2 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 06/18/2009 | WO2009075838A2 Treatment of menorrhagia with aromatase inhibitor |
| 06/18/2009 | WO2009075835A1 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 06/18/2009 | WO2009075830A1 Inhibitors of janus kinases |
| 06/18/2009 | WO2009075826A1 Methods for increasing white blood cells |
| 06/18/2009 | WO2009075824A1 Methods for increasing endothelial progentior cells |
| 06/18/2009 | WO2009075822A1 Methods for inhibiting t helper cell differentiation |
| 06/18/2009 | WO2009075806A1 Methods and compositions for treating liquid tumors |
| 06/18/2009 | WO2009075790A1 Metalloprotease inhibitors for intra-articular application |
| 06/18/2009 | WO2009075782A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
| 06/18/2009 | WO2009075776A1 Process for the preparation of retapamulin and its intermediates |
| 06/18/2009 | WO2009075691A1 Cb-1 modulating compounds and their use |
| 06/18/2009 | WO2009075677A1 O-desmethyl-venlafaxine for treating major depressive disorder |
| 06/18/2009 | WO2009075610A1 Use of benomyl fungicide as an agent for treating oncological diseases |
| 06/18/2009 | WO2009075573A1 Paediatric fibre mixture |
| 06/18/2009 | WO2009075564A1 Paediatric fibre mixture |
| 06/18/2009 | WO2009075557A1 Fluorobenzenamides having anti-convulsive activity |
| 06/18/2009 | WO2009075391A1 Drug-containing nanoparticles |
| 06/18/2009 | WO2009075344A1 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof |
| 06/18/2009 | WO2009075334A1 Uterine fibroid cell growth inhibitor, and prophylactic or therapeutic agent for uterine fibroid comprising the inhibitor |
| 06/18/2009 | WO2009075324A1 Loxoprofen-containing aqueous plaster |
| 06/18/2009 | WO2009075323A1 Stable crystal of β-lactam compound |
| 06/18/2009 | WO2009075309A1 Preparation composition |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009075258A1 Transdermally absorptive preparation |
| 06/18/2009 | WO2009075142A1 Bactericidal cleanser composition |
| 06/18/2009 | WO2009075094A1 Tape preparation comprising etodolac in ionic liquid form |
| 06/18/2009 | WO2009074995A1 Taste masked chewable compositions of sildenafil citrate |